Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease
- 22 November 2005
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 27 (12) , 1763-1768
- https://doi.org/10.1016/j.neurobiolaging.2005.10.007
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's diseaseNeurobiology of Aging, 2005
- Mild cognitive impairment as a diagnostic entityJournal of Internal Medicine, 2004
- Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegenerationJournal of Neuroimmunology, 2003
- Chemokine Expression in Myocardial Ischemia: MIP-2 Dependent MCP-1 Expression Protects Cardiomyocytes from Cell DeathJournal of Molecular and Cellular Cardiology, 2002
- Elevated Levels of FMR1 mRNA in Carrier Males: A New Mechanism of Involvement in the Fragile-X SyndromeAmerican Journal of Human Genetics, 2000
- Increase in Circulating Levels of Monocyte Chemoattractant Protein-1 with AgingJournal of Interferon & Cytokine Research, 1999
- Chemokines/chemokine receptors in the central nervous system and Alzheimer's diseaseJournal of NeuroVirology, 1999
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984